New therapy helps anxious kids before problems grow
NCT ID NCT00865306
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a therapy program called 'Being Brave' for children ages 4 to 7 who were at risk for anxiety disorders. The program involved parents and children learning coping skills together. Researchers compared 65 children who received the therapy to those on a waitlist. Results showed that children in the therapy group had greater improvement in anxiety symptoms.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- cognitive-behavioral therapy (CBT) program called 'Being Brave'
- What this could lead to
- If successful, this could provide an effective early intervention to reduce anxiety in young children and prevent long-term issues.
- What could go wrong
- This was a small pilot study with only 65 children, so results may not apply to everyone. The intervention requires significant parent involvement, which may not work for all families.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
65 people
The number who actually took part.
- Start date
-
Mar 1998
- Finished
-
Jan 2005
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
4 to 7 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * The child is at risk for anxiety disorders, as indicated by at least one of the following: * the child has behavioral inhibition (as determined by observed behavioral assessment); * the child meets criteria for a DSM-IV or IIIR anxiety disorder (as determined by Kiddie-Schedule for Affective Disorders and Schizophrenia, Epidemiologic Version \[K-SADS-E\] with the mother); or * the child has both a parent with lifetime history of anxiety disorder (as determined by direct Structured Clinical Interview for DSM-IV \[SCID-IV\] with both parents) and the child has anxious symptomatology, as indicated by Child Behavior Checklist \[CBCL\] scale scores (T-scores) on Anxious/Depressed or Withdrawn of 55 or higher. * The child is between the ages of 4 and 7 years * The child and parent(s) have a working command of English Exclusion Criteria: * Psychosis in parent or child * Suicidality in parent or child * Current alcohol or substance abuse in a parent * Mental retardation or pervasive developmental disorder in parent or child * Child in current psychiatric treatment * Child judged too uncooperative or distractible to take part in intervention * (In the controlled trial): Child judged clinically unable to wait six months for treatment. The following criteria are used in determining whether the child can wait for 6 months before receiving treatment: * Suicidal Ideation * Serious impairment in eating or sleeping habits * Severe social isolation * Severe impairment in school functioning or attendance * Severe symptoms of obsessive-compulsive disorder (OCD) * Clinical judgment based on the child's overall severity of symptoms and family functioning. * All judgments of severity of symptoms/impairment are based on a clinician review of the Kiddie-SADS-E and a clinical evaluation with the family.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Anxiety disorder are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Massachusetts General Hospital
Cambridge, Massachusetts, 02138, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a Web-Based therapy ease common mental health struggles?
- Can a pressurized oxygen chamber keep brain benefits alive months later?
- France pilots collaborative mental health model in primary care
- New LGBTQ-Affirmative therapy aims to curb heavy drinking in queer women
- Online group therapy helps workers with depression get back on the job
- New therapy aims to help teens battling addiction and anxiety